In the present study we sought to identify the naturally processed and presented immunopeptidome of the SARS-CoV-2 spike glycoprotein from human antigen presenting cells. Monocyte-derived dendritic cells from a panel of healthy human subjects representing a majority of the HLA-DRB1 allele usage within the United States were treated with recombinant spike glycoprotein. A subset of donors was also selected to represent common alleles from the Asia- Pacific geography. HLA II associated peptides were identified by liquid chromatography and nanoelectrospray ionization tandem mass spectrometry after immunoprecipitation.
[doi:10.25345/C51M7P]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: SARS-CoV-2 ; Immunopeptidomics ; dendritic cells ; HLA-II ; MAPPs ; spike glycoprotein ; human
Principal Investigators: (in alphabetical order) |
Mike Knierman, Eli Lilly and Co., USA Robert Siegel, Eli Lilly and Co., United States |
Submitting User: | mknierman |
Knierman MD, Lannan MB, Spindler LJ, McMillian CL, Konrad RJ, Siegel RW.
The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein.
Cell Rep. 2020 Dec 1;33(9):108454. Epub 2020 Nov 13.
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
|
||
Biological Replicates:
|
||
Technical Replicates:
|
||
Identification Results | ||
Proteins (Human, Remapped):
|
||
Proteins (Reported):
|
||
Peptides:
|
||
Variant Peptides:
|
||
PSMs:
|
||
Quantification Results | ||
Differential Proteins:
|
||
Quantified Proteins:
|
||
Browse Dataset Files | |
FTP Download Link (click to copy):
|